This management's discussion and analysis should be read in conjunction with the
consolidated financial statements and notes included elsewhere in this Quarterly
Report on Form 10-Q. All amounts described in this section are in thousands,
except percentages, periods of time, and share and per share data.



This management's discussion and analysis, as well as other sections of this
Quarterly Report on Form 10-Q, may contain "forward-looking statements" that
involve risks and uncertainties, including statements regarding our plans,
future events, objectives, expectations, estimates, forecasts, assumptions, or
projections. Any statement that is not a statement of historical fact is a
forward-looking statement, and in some cases, words such as "believe,"
"estimate," "project," "expect," "intend," "may," "anticipate," "plan," "seek,"
and similar words or expressions identify forward-looking statements. These
statements involve risks and uncertainties that could cause actual outcomes and
results to differ materially from the anticipated outcomes or results, and undue
reliance should not be placed on these statements. These risks and uncertainties
include, but are not limited to, the matters discussed in Part II herein, under
the heading "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2021 and other risks and uncertainties discussed
in other filings made with the Securities and Exchange Commission (including
risks described in subsequent reports on Form 10-Q and Form 8-K and other
filings). We disclaim any intention or obligation, other than as required by
applicable law, to update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise.



Overview



We are a materials technology company that develops and commercializes products
made from amorphous alloys. Our Liquidmetal® family of alloys consists of a
variety of proprietary bulk alloys and composites that utilize the advantages
offered by amorphous alloy technology. We design, develop, and sell custom
products and parts from bulk amorphous alloys to customers in various
industries. We also partner with third-party manufacturers and licensees to
develop and commercialize Liquidmetal alloy products.



Amorphous alloys are, in general, unique materials that are distinguished by
their ability to retain a random atomic structure when they solidify, in
contrast to the crystalline atomic structure that forms in other metals and
alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys
that possess a combination of performance, processing, and potential cost
advantages that we believe will make them preferable to other materials in a
variety of applications. The amorphous atomic structure of bulk alloys enables
them to overcome certain performance limitations caused by inherent weaknesses
in crystalline atomic structures, thus facilitating performance and processing
characteristics superior in many ways to those of their crystalline
counterparts. We believe the alloys and the molding technologies we employ can
result in components for many applications that exhibit exceptional dimensional
control and repeatability that rivals precision machining, excellent corrosion
resistance, brilliant surface finish, high strength, high hardness, high elastic
limit, alloys that are non-magnetic, and the ability to form complex shapes
common to the injection molding of plastics. All of these characteristics are
achievable from the molding process, so design engineers often do not have to
select specific alloys to achieve one or more of the characteristics as is the
case with crystalline materials. We believe these advantages could result in
Liquidmetal alloys supplanting high-performance alloys, such as titanium and
stainless steel, and other incumbent materials in a wide variety of
applications. Moreover, we believe these advantages could enable the
introduction of entirely new products and applications that are not possible or
commercially viable with other materials.



Licensing Transactions



Eontec License Agreement



On March 10, 2016, we entered into a Parallel License Agreement (the "License
Agreement") with DongGuan Eontec Co., Ltd., a Hong Kong corporation ("Eontec")
pursuant to which the parties agreed to cross-license certain patents, technical
information, and trademarks between us and Eontec. In particular, we granted to
Eontec a paid-up, royalty-free, perpetual license to our patents and related
technical information to make, have made, use, offer to sell, sell, export, and
import products in certain geographic areas outside of North America and Europe,
and Eontec granted to us a paid-up, royalty-free, perpetual license to Eontec's
patents and related technical information to make, have made, use, offer to
sell, sell, export, and import products in certain geographic areas outside of
specified countries in Asia. The license granted by us to Eontec is exclusive
(including to the exclusion of us) in the countries of Brunei, Cambodia, China
(P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar,
Philippines, Singapore, South Korea, Thailand, and Vietnam. The license granted
by Eontec to us is exclusive (including to the exclusion of Eontec) in North
America and Europe. The cross-licenses are non-exclusive in geographic areas
outside of the foregoing exclusive territories.



Beyond the License Agreement, we collaborate with Eontec to accelerate the commercialization of amorphous alloy technology. This includes but is not limited to developing technologies to reduce the cost of amorphous alloys, working on die cast machine technology platforms to pursue broader markets, sharing knowledge to broaden our intellectual property portfolio, and utilizing Eontec's volume production capabilities as a third party contract manufacturer.





                                       19

--------------------------------------------------------------------------------

Table of Contents

Eutectix Business Development Agreement





On January 31, 2020, we entered into a Business Development Agreement (the
"Agreement") with Eutectix, LLC, a Delaware limited liability company
("Eutectix"), which provides for collaboration, joint development efforts, and
the manufacturing of products based on our proprietary amorphous metal alloys.
Under the Agreement, we have agreed to license to Eutectix specified equipment
owned by us, including two injection molding machines, the Machines, and other
machines and equipment, all of which will be used to make products for our
customers and Eutectix customers. The licensed machines and equipment represent
substantially all of the machinery and equipment currently held by us. We have
also licensed to Eutectix various patents and technical information related to
our proprietary technology. Under the Agreement, Eutectix will pay us a royalty
of six percent (6%) of the net sales price of licensed products sold by
Eutectix, and Eutectix will also manufacture products for us. The Agreement has
a term of five years, subject to renewal provisions and the ability of either
party to terminate earlier upon specified circumstances.



Apple License Transaction



On August 5, 2010, we entered into a license transaction with Apple pursuant to
which (i) we contributed substantially all of our intellectual property assets
to a newly organized special-purpose, wholly-owned subsidiary, called Crucible
Intellectual Property, LLC ("CIP"), (ii) CIP granted to Apple a perpetual,
worldwide, fully-paid, exclusive license to commercialize such intellectual
property in the field of consumer electronic products, as defined in the license
agreement, in exchange for a license fee, and (iii) CIP granted back to us a
perpetual, worldwide, fully-paid, exclusive license to commercialize such
intellectual property in all other fields of use.



Under the agreements relating to the license transaction with Apple, we were
obligated to contribute, to CIP, all intellectual property developed by us
through February 2016. We are also obligated to maintain certain limited
liability company formalities with respect to CIP at all times after the closing
of the license transaction.


Other Material License Transactions





On January 13, 2022, our majority owned subsidiary, Liquidmetal Golf ("LMG"),
entered into a sublicense agreement ("LMG Sublicense Agreement") with Amorphous
Technologies Japan, Inc. ("ATJ"), a newly formed Japanese entity that was
established by Twins Corporation, a sporting goods company operating in Japan.
Under the agreement, LMG granted to ATJ a nonexclusive worldwide sublicense to
our amorphous alloy technology and related trademarks to manufacture and sell
golf clubs and golf related products. The LMG Sublicense Agreement has a term of
three years and provides for the payment of a running royalty to LMG of 3% of
the net sales price of licensed products.



In March 2009, we entered into a license agreement with Swatch Group, Ltd.
("Swatch") under which Swatch was granted a non-exclusive license to our
technology to produce and market watches and certain other luxury products. In
March 2011, this license agreement was amended to grant Swatch exclusive rights
as to watches and all third parties (including us), but non-exclusive as to
Apple. We will receive royalty payments over the life of the contract on all
Liquidmetal products produced and sold by Swatch. The license agreement with
Swatch will expire on the expiration date of the last licensed patent.



Critical Accounting Policies and Estimates





The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States requires us to
make estimates and assumptions that affect reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. These estimates and assumptions are based on
historical experience and various other factors that are believed to be
reasonable under the circumstances. Actual results could differ materially from
these estimates under different assumptions or conditions.



We believe that the following accounting policies are the most critical to our
consolidated financial statements since these policies require significant
judgment or involve complex estimates that are important to the portrayal of our
financial condition and operating results:



  • Revenue recognition
  • Impairment of long-lived assets and definite-lived intangibles
  • Deferred tax assets
  • Share based compensation




Our Annual Report on Form 10-K for the year ended December 31, 2021 (the "2021
Annual Report") contains further discussions on our critical accounting policies
and estimates.



                                       20

--------------------------------------------------------------------------------


  Table of Contents



Results of Operations


Comparison of the three and six months ended June 30, 2022 and 2021





                                 For the three months ended June 30,                                   For the six months ended June 30,
                    2022                                  2021                             2022                               2021
                  in 000's         % of Revenue         in 000's      % of

Revenue in 000's % of Revenue in 000's % of Revenue

Revenue:


Products          $     103                            $      231                       $       266                         $     294
Licensing and
royalties                22                                    12                                22                                21
Total revenue           125                                   243                               288                               315

Cost of sales            84                   67 %            154                63 %           228                  79 %         209                66 %
Gross profit             41                   33 %             89                37 %            60                  21 %         106                34 %

Selling,
marketing,
general and
administrative          771                  617 %            849               349 %         1,575                 547 %       1,728               549 %
Research and
development              17                   14 %             38                16 %            27                   9 %          60                19 %
Total operating
expense                 788                                   887                             1,602                             1,788

Operating loss         (747 )                                (798 )                          (1,542 )                          (1,682 )

Lease income            132                                   132                               265                               264
Interest and
investment
income (loss)             -                                    41                                (5 )                             102
Net loss          $    (615 )                          $     (625 )                     $    (1,282 )                       $  (1,316 )

Revenue and operating expenses





Revenue. Total revenue decreased to $125 for the three months ended June 30,
2022 from $243 for the three months ended June 30, 2021. Total revenue decreased
to $288 for the six months ended June 30, 2022 from $315 for the six months
ended June 30, 2021. The decrease for both period was attributable to lower
general production shipments of products made by our contract manufacturers and
decreases in payments under development projects, following the Company's
transition to outsourced manufacturing in 2020.



Cost of sales. Cost of sales was $84, or 67% of total revenue, for the three
months ended June 30, 2022, a decrease from $154, or 63% of total revenue, for
the three months ended June 30, 2021. Cost of sales was $288, or 79% of total
revenue, for the six months ended June 30, 2022, an increase from $209, or 66%
of total revenue, for the six months ended June 30, 2021. The decrease for the
three months ended June 30, 2022 and 2021 was attributable to lower products
revenue, increase in licensing and royalties revenue, and lower gross profit
percentages. The increase for the six months ended June 30, 2022 and 2021 was
attributable to higher products revenue, increase in licensing and royalties
revenue, and lower gross profit percentages. If we begin increasing our products
revenues with shipments of routine, commercial products and parts through third
party contract manufacturers, we expect our cost of sales percentages to
decrease, stabilize and be more predictable.



Gross profit. Our gross profit decreased to $41 for the three months ended June
30, 2022 from $89 for the three months ended June 30, 2021. Our gross profit as
a percentage of total revenue, decreased to 33% for the three months ended June
30, 2022 from 37% for the three months ended June 30, 2021. Our gross profit
decreased to $60 for the six months ended June 30, 2022 from $106 for the six
months ended June 30, 2021. Our gross profit as a percentage of total revenue,
decreased to 21% for the six months ended June 30, 2022 from 34% for the six
months ended June 30, 2021. Early prototype and pre-production orders generally
result in a higher cost mix, relative to revenue, than would otherwise be
incurred in an on-site production environment, with higher volumes and more
established operating processes, or through contract manufacturers. As such, our
gross profit percentages have fluctuated and may continue to fluctuate based on
volume and quoted production prices per unit and may not be representative of
our future business. If we begin increasing our products revenues with shipments
of routine, commercial products and parts through future orders to third party
contract manufacturers, we expect our gross profit percentages to stabilize,
increase, and be more predictable.



Selling, marketing, general and administrative. Selling, marketing, general, and
administrative expenses were $771 and $1,575 for the three and six months ended
June 30, 2022, respectively, compared to $849 and $1,728 for the three and six
months ended June 30, 2021, respectively. The decrease in expenses was primarily
attributable to lower stock based compensation as well as continued cost
reductions.



                                       21

--------------------------------------------------------------------------------

Table of Contents





Research and development. Research and development expenses were $17 and $27 for
the three and six months ended June 30, 2022, respectively, compared to $38 and
$60 for the three and six months ended June 30, 2021, respectively. We continue
to perform research and development of new Liquidmetal alloys and related
processing capabilities, albeit on a reduced basis in comparison with prior
periods.



Operating loss. Operating loss was $747 and $1,542 for the three and six months
ended June 30, 2022, respectively. This compares to $798 and $1,682 for the
three and six months ended June 30, 2021, respectively. Fluctuations in our
operating loss are primarily attributable to variations in operating expenses,
as discussed above.



We continue to invest in our technology infrastructure to expedite the adoption
of our technology, but we have experienced long sales lead times for customer
adoption of our technology. Until that time when we can either (i) increase our
revenues with shipments of routine, commercial products and parts through third
party contract manufacturers or (ii) obtain significant licensing revenues, we
expect to continue to have operating losses for the foreseeable future.



Other income and expenses



Lease income. Lease income relates to straight-line rental income received under
the Facility Lease. Such amounts were $132 and $265 for the three and six months
ended June 30, 2022, respectively. This compares to $132 and $264 for the three
and six months ended June 30, 2021, respectively.



Interest and investment income (loss). Interest and investment income (loss)
relates to interest earned from our cash deposits and investments in debt
securities for the respective periods. Interest and investment loss was $0 and
$5 for the three and six months ended June 30, 2021, respectively. This compares
to interest and investment income of $41 and $102 during the three and six
months ended June 30, 2021, respectively. The decrease during 2022 is due
continued volatility in corporate debt and bond markets, which is resulting in
reduced yields.


Liquidity and Capital Resources

Cash used in operating activities

Cash used in operating activities totaled $762 and $724 for the six months ended June 30, 2022 and 2021, respectively. The cash was primarily used to fund operating expenses related to our business and product development efforts.

Cash provided (used in) by investing activities

Cash used in investing activities totaled $486 and provided by investing activities totaled $10,135 for the six months ended June 30, 2022 and 2021, respectively. Investing inflows primarily consist of proceeds from the sale of debt securities. Investing outflows primarily consist of purchases of debt securities.

Cash provided by financing activities





Cash provided by financing activities totaled $212 for the six months ended June
30, 2022 related to the exercise of our stock options, and $0 for the six months
ended June 30, 2021.


Financing arrangements and outlook





We have a relatively limited history of selling bulk amorphous alloy products
and components on a mass-production scale. Furthermore, the ability of future
contract manufacturers to produce our products in desired quantities and at
commercially reasonable prices is uncertain and is dependent on a variety of
factors that are outside of our control, including the nature and design of the
component, the customer's specifications, and required delivery timelines. These
factors have previously required that we engage in equity sales under various
stock purchase agreements to support its operations and strategic initiatives.



However, as of June 30, 2022, we had $3,055 in cash and restricted cash, as well
as $22,320 in investments in debt securities. We view this total of $25,375 as
readily available sources of liquidity in the event needed to advance our
existing strategy, and/or pursue an alternative strategy. As such, we anticipate
that our current capital resources, when considering expected losses from
operations, will be sufficient to fund our operations for the foreseeable
future.



                                       22

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses